Panitumumab interaction with<scp>TAS</scp>‐102 leads to combinational anticancer effects via blocking of<scp>EGFR</scp>‐mediated tumor response to trifluridine
Yuji Baba(Takeda (Japan)), Kazuhide Nakamura(Takeda (Japan))
Cited by 22
Related Papers
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
|Molecular Cancer Therapeutics|2004|66